Evidence map›Paper›PMID 41926391›Full record

ArticlePloS one2026

Functionalized calcium carbonate microparticles in ethyl cellulose films: A vehicle for sustained amoxicillin release for medical applications.

Petru Niga, Simone Sala, Jenny Rissler, Lina Nyström, Anna Fureby, Ulla Elofsson, Joachim Schoelkopf, Roger Roth, Patrick Gane

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Petru NigaChemical Process and Pharmaceutical Development, RISE - Research Institute of Sweden, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-0195-3850
Simone SalaChemical Process and Pharmaceutical Development, RISE - Research Institute of Sweden, Stockholm, Sweden.
Jenny RisslerChemical Process and Pharmaceutical Development, RISE - Research Institute of Sweden, Stockholm, Sweden.
Lina NyströmChemical Process and Pharmaceutical Development, RISE - Research Institute of Sweden, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-5236-9107
Anna FurebyChemical Process and Pharmaceutical Development, RISE - Research Institute of Sweden, Stockholm, Sweden.
Ulla ElofssonChemical Process and Pharmaceutical Development, RISE - Research Institute of Sweden, Stockholm, Sweden.
Joachim SchoelkopfOmya International AG, Egerkingen, Switzerland.
Roger RothOmya International AG, Egerkingen, Switzerland.
Patrick GaneOmya International AG, Egerkingen, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The continuous quest for materials capable of providing sustained release of antimicrobial drugs is particularly important for indwelling medical applications. In this study, we utilized amoxicillin as a model active pharmaceutical ingredient (API) to investigate the feasibility of using porous media - specifically, functionalized calcium carbonate (FCC) microparticles - as a primary drug carrier embedded within an ethyl cellulose (EC) polymer film. Our main objective was to prolong and sustain the release of the API. The fabrication process of the microparticle containing film involved two key steps: loading the model API into the FCC particles and then embedding these loaded particles into the polymeric film. Amoxicillin was loaded into the FCC particles using a solvent evaporation method. Detailed characterization through Scanning Electron Microscopy (SEM), lab- and synchrotron-based XRD revealed that amoxicillin precipitated both inside and on the surface of the FCC particles, predominantly in an amorphous form. Additionally, ultraviolet-visible (UV-vis) spectroscopic data demonstrated an increased release rate from the porous FCC compared to direct dissolution of pure amoxicillin powder. Embedding amoxicillin pre-loaded porous FCC particles in the EC film led to a more rational sustained release compared with powder amoxicillin embedded directly in the film, advantageously delivering the same amount of amoxicillin over a longer period; a result that may be relevant for indwelling medical devices such as urinary catheters, vascular access devices or wound drains.

Indexed as

AmoxicillinCalcium CarbonateCelluloseDrug CarriersAnti-Bacterial AgentsBulk DrugsDelayed-Action PreparationsDrug LiberationMicroscopy, Electron, ScanningPorosityAmoxicillinAnti-Bacterial AgentsBulk DrugsCalcium CarbonateCelluloseDelayed-Action PreparationsDrug Carriersethyl cellulose

Identifiers

PMID41926391
PMCPMC13046161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.